# Biogen (BIIB) — Overview

BIIB · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/biib

## Price

Last close $235.35 on Oct 15, 2026. 52-week range $142.26 – $235.35.

## Company profile

Biogen is an established biopharmaceutical company focused on treatments for neurodegenerative and rare diseases. Its declining multiple sclerosis franchise is its largest revenue generator and contributed 40% of total revenue in 2025. Biogen also generates significant revenue from its CD20 collaboration agreements with Roche (19% of total in 2025), which includes oncology drugs Rituxan and Gazyva and multiple sclerosis drug Ocrevus. Biogen's newer franchises include Spinraza (spinal muscular atrophy, with partner Ionis), Leqembi (Alzheimer's disease, collabroation revenue from its partner Eisai), Skyclarys (Friedreich's ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (amyotrophic lateral sclerosis, Ionis).

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $10.0B |
| Revenue (quarter) | $2.7B |
| Revenue growth (year over year) | 3.42% |
| Gross profit (trailing twelve months) | $7.4B |
| Gross margin | 73.99% |
| Net income (trailing twelve months) | $834.6M |
| Net income (quarter) | $97.5M |
| Net income growth (year over year) | -84.64% |
| Net margin | 8.32% |
| Return on equity | 4.58% |
| EPS (trailing twelve months) | $5.68 |
| Book value per share | $127.61 |
| P/E (trailing twelve months) | 41.7 |
| Price to book | 1.8 |
| Debt to assets | 41.26% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Biogen (BIIB) profitable?

Yes. Biogen earned $834.6M in net income over the trailing twelve months, a net margin of 8.32%.

### How much revenue does Biogen (BIIB) make?

Biogen generated $10.0B in revenue over the trailing twelve months, up 3.42% year over year.

### What is BIIB's P/E ratio?

Biogen trades at 41.7 times trailing twelve-month earnings, on an EPS of $5.68.

### How do I buy stock in Biogen (BIIB)?

BIIB trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

## Similar Stocks

- [LLY](https://www.lighthorse.io/tickers/lly) — Eli Lilly and Company Common Stock
- [IONS](https://www.lighthorse.io/tickers/ions) — Ionis Pharmaceuticals, Inc. - Common Stock
- [AMGN](https://www.lighthorse.io/tickers/amgn) — Amgen Inc. - Common Stock
- [VRTX](https://www.lighthorse.io/tickers/vrtx) — Vertex Pharmaceuticals Incorporated - Common Stock
- [PRTA](https://www.lighthorse.io/tickers/prta) — Prothena Corporation plc - Ordinary Shares
- [MRNA](https://www.lighthorse.io/tickers/mrna) — Moderna, Inc. - Common Stock
- [GILD](https://www.lighthorse.io/tickers/gild) — Gilead Sciences, Inc. - Common Stock
- [BMY](https://www.lighthorse.io/tickers/bmy) — Bristol-Myers Squibb Company Common Stock
- [ABBV](https://www.lighthorse.io/tickers/abbv) — AbbVie Inc. Common Stock
- [JNJ](https://www.lighthorse.io/tickers/jnj) — Johnson & Johnson Common Stock

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).